MarineMax
HZO
52.47
+0.08
+0.15%
MarineMax
US · HZO
#3149 by market cap
52.47
+0.08
+0.15%
Live - 5344 symbols - heartbeat 293s ago
· 2026-10-08 08:09
Pre-market
52.32
-0.29%
After-hours
52.47
0.00%
- Market cap
- 1.16B
- P/E (TTM)i
- 327.94
- P/Bi
- 1.22
- EPSi
- -1.43
- Div yieldi
- 0.00%
- 52W posi
- 100%
Reader sentiment
Are you bullish or bearish on HZO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.05, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -5.01% YoY
Margins
- Gross margin
- 32.49%
- Operating margin
- 4.46%
- Net margin
- -1.37%
Key ratios & quality
- Enterprise valuei
- 2.11B
- Altman Z-Scorei
- 2.05
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.24B | 1.51B | 2.06B | 2.31B | 2.39B | 2.43B | 2.31B |
| Gross profit | 298.23M | 322.83M | 398.71M | 659.43M | 805.75M | 835.33M | 801.20M | 750.23M |
| Selling & admin expenses | 235.05M | 262.30M | 292.00M | 449.97M | 540.55M | 634.53M | 672.97M | 647.16M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 63.18M | 60.53M | 106.72M | 209.46M | 265.20M | 200.80M | 128.23M | 103.07M |
| Pretax profit | 53.28M | 48.95M | 97.44M | 205.79M | 261.92M | 147.44M | 54.33M | -37.14M |
| Tax | 13.97M | 12.97M | 22.81M | 50.82M | 63.93M | 37.96M | 15.59M | -6.38M |
| Net profit | 39.31M | 35.99M | 74.63M | 154.98M | 197.99M | 109.48M | 38.74M | -30.77M |
| Basic EPS | 2 | 2 | 3 | 7 | 9 | 5 | 2 | -1 |
| Diluted EPS | 1.71 | 1.57 | 3.37 | 6.78 | 8.84 | 4.87 | 1.65 | -1.43 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 631.52M | 657.16M | 552.15M | 505.18M | 527.41M | 611.26M |
| Gross profit | 189.51M | 199.62M | 191.44M | 160.47M | 181.29M | 218.08M |
| Selling & admin expenses | 166.77M | 172.11M | 177.60M | 155.55M | 170.45M | 180.86M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 22.74M | 27.52M | 13.84M | 4.92M | 10.84M | 37.22M |
| Pretax profit | 4.56M | -58.48M | -3.45M | -10.94M | -3.82M | 22.91M |
| Tax | 1.40M | -6.51M | -3.37M | -2.84M | -1.11M | 7.26M |
| Net profit | 3.16M | -51.97M | -82.00K | -8.10M | -2.72M | 15.65M |
| Basic EPS | 0 | -2 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.14 | -2.42 | -0.04 | -0.36 | -0.12 | 0.66 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 465.29M | 568.58M | 503.33M | 517.52M | 754.00M | 1.12B | 1.27B | 1.18B |
| Cash & ST investments | 48.82M | 38.51M | 155.49M | 222.19M | 228.27M | 201.46M | 224.33M | 170.35M |
| Inventory | 377.07M | 477.47M | 298.00M | 230.98M | 454.36M | 812.83M | 906.64M | 867.33M |
| Total assets | 640.54M | 784.08M | 775.32M | 1.01B | 1.35B | 2.42B | 2.61B | 2.47B |
| Total current liabilities | 286.02M | 412.89M | 272.53M | 251.09M | 412.77M | 847.05M | 1.07B | 984.88M |
| Short-term debt | 212.95M | 312.07M | 151.75M | 38.10M | 144.60M | 580.90M | 752.52M | 761.76M |
| Long-term debt | -- | -- | 7.34M | 47.50M | 45.30M | 389.23M | 355.91M | 356.24M |
| Total liabilities | 287,446,000.00 | 415,264,000.00 | 319,922,000.00 | 412,931,000.00 | 570,105,000.00 | 1,502,888,000.00 | 1,618,819,000.00 | 1,521,685,000.00 |
| Total equity | 353.09M | 368.82M | 455.40M | 594.89M | 782.67M | 918.42M | 986.25M | 948.75M |
| Retained earnings | 166.07M | 202.46M | 277.70M | 432.68M | 630.67M | 739.95M | 778.02M | 746.38M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.32B | 1.20B | 1.18B | 1.14B | 1.16B | 1.09B |
| Cash & ST investments | 203.51M | 151.02M | 170.35M | 164.60M | 189.13M | 174.78M |
| Inventory | 973.41M | 906.22M | 867.33M | 867.90M | 845.37M | 788.64M |
| Total assets | 2.67B | 2.49B | 2.47B | 2.43B | 2.44B | 2.36B |
| Total current liabilities | 1.14B | 991.15M | 984.88M | 961.34M | 983.44M | 880.96M |
| Short-term debt | 865.66M | 780.85M | 761.76M | 749.07M | 736.75M | 647.34M |
| Long-term debt | 339.05M | 365.07M | 356.24M | 347.49M | 338.73M | 335.17M |
| Total liabilities | 1,669,722,000.00 | 1,536,414,000.00 | 1,521,685,000.00 | 1,483,999,000.00 | 1,498,138,000.00 | 1,394,429,000.00 |
| Total equity | 1.00B | 951.32M | 948.75M | 944.32M | 943.42M | 963.91M |
| Retained earnings | 799.39M | 747.24M | 746.38M | 738.46M | 735.86M | 751.22M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 70.41M | -12.43M | 304.68M | 373.88M | 76.60M | -222.24M | -25.66M | 72.81M |
| Depreciation & amortization | 10.67M | 11.60M | 12.77M | 15.61M | 19.42M | 41.03M | 44.49M | 49.32M |
| Free cash flow | 56.61M | -29.49M | 291.87M | 347.76M | 18.14M | -287.64M | -86.08M | 11.94M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -695.00K | -27.71M | -631.00K | -23.77M | -21.29M | 0 | -2.14M | -27.48M |
| Ending cash balance | 48.82M | 38.51M | 155.49M | 222.19M | 228.27M | 201.46M | 224.33M | 170.35M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 72.50M | 84.94M | 61.45M | 16.88M | 55.47M | 85.21M |
| Depreciation & amortization | 12.25M | 12.54M | 12.94M | 12.58M | 12.71M | 12.59M |
| Free cash flow | 59.84M | 68.50M | 48.00M | 8.34M | 44.50M | 77.18M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -15.05M | 0 | -- | -- | 0 |
| Ending cash balance | 203.51M | 151.02M | 170.35M | 164.60M | 189.13M | 174.78M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.00 | 9.97 | 18.11 | 29.51 | 28.74 | 12.87 | 4.02 | -3.31 |
| ROA %i | 6.14 | 5.05 | 9.57 | 17.38 | 16.77 | 5.79 | 1.51 | -1.25 |
| ROIC %i | 8.31 | 7.14 | 11.94 | 22.14 | 21.79 | 9.70 | 4.30 | 1.24 |
| 5-year avg ROE %i | 10.12 | 11.14 | 11.06 | 15.45 | 19.67 | 19.84 | 18.65 | 14.37 |
| EBIT margin %i | 5.37 | 4.89 | 7.07 | 10.15 | 11.49 | 8.39 | 5.27 | 1.47 |
| FCF / sales %i | 4.81 | -- | 19.33 | 16.85 | 0.79 | -- | -- | 0.52 |
| Current ratioi | 1.63 | 1.38 | 1.85 | 2.06 | 1.83 | 1.33 | 1.19 | 1.20 |
| Quick ratioi | 0.29 | 0.20 | 0.72 | 1.07 | 0.67 | 0.34 | 0.31 | 0.28 |
| Debt / assetsi | 33.25 | 39.80 | 24.84 | 18.11 | 20.67 | 45.18 | 47.33 | 50.44 |
| LT debt / equityi | -- | -- | 8.96 | 24.28 | 17.24 | 56.02 | 49.23 | 51.67 |
| Interest coveragei | 6.38 | 5.23 | 11.51 | 57.15 | 80.78 | 3.76 | 1.74 | 0.48 |
| Revenue CAGR (3Y) %i | 16.15 | 9.51 | 12.78 | 20.56 | 23.11 | 16.62 | 5.62 | 0.02 |
| Net income CAGR (3Y) %i | -6.63 | 16.80 | 46.89 | 57.97 | 76.54 | 13.55 | -37.37 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | 83.14 | -- | -- | -- | -13.01 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.91 | -2.81 | -3.31 | -5.98 | -6.60 | 0.42 |
| ROA %i | 2.15 | -1.05 | -1.25 | -2.28 | -2.48 | 0.16 |
| ROIC %i | 4.94 | 1.21 | 1.24 | -0.03 | -0.47 | 1.93 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.18 | 2.02 | 1.47 | 0.00 | -0.53 | 3.04 |
| FCF / sales %i | -- | -- | 0.52 | 7.87 | 7.55 | 8.11 |
| Current ratioi | 1.16 | 1.21 | 1.20 | 1.19 | 1.18 | 1.23 |
| Quick ratioi | 0.28 | 0.26 | 0.28 | 0.26 | 0.30 | 0.31 |
| Debt / assetsi | 49.89 | 51.20 | 50.44 | 50.42 | 49.37 | 47.06 |
| LT debt / equityi | 47.10 | 52.41 | 51.67 | 50.95 | 50.28 | 48.55 |
| Interest coveragei | 2.05 | 0.65 | 0.48 | 0.00 | -0.18 | 1.08 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Retail operations is the largest reported line at 99.65% of revenue, across 3 reported segments.
- The next-largest line, Product Manufacturing, is a distant second at 5.44% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Retail operations99.65%
Product Manufacturing5.44%
Quote time 2026-10-08 08:09:07 · For reference only, not investment advice and not tailored to your situation.